Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections

Dr. Allison C. Rosenthal

Hematology Oncology | Hematology
Mayo Clinic Arizona
5701 E Mayo Blvd, 
Phoenix, AZ 
Offers Telehealth
16 Years of Experience
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Mayo Clinic Arizona
5701 E Mayo Blvd, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Allison Rosenthal is a Hematologist Oncology specialist and a Hematologist in Phoenix, Arizona. Dr. Rosenthal has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 109 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Hematology Oncology
Hematology
Licenses
Internal Medicine in AZ
Hospital Affiliations
Mayo Clinic Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

MAYO CLINIC ARIZONA
5701 E Mayo Blvd, Phoenix, AZ 85054
Other Locations
MAYO CLINIC ARIZONA
5777 E Mayo Blvd, Mayo Clinic Hospital, Phoenix, AZ 85054
MAYO CLINIC ARIZONA
13400 E Shea Blvd, Scottsdale, AZ 85259

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase I/Ib Open-label, Multi-center Dose Escalation Study of JBH492 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
A Phase I/Ib Open-label, Multi-center Dose Escalation Study of JBH492 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL)
Enrollment Status: Terminated
Publish Date: October 10, 2025
Intervention Type: Drug
Study Drug: JBH492 Anti-CCR7 Antibody-Drug Conjugate
Study Phase: Phase 1
A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
A Phase I Study With an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS)
Enrollment Status: Active_not_recruiting
Publish Date: September 25, 2025
Intervention Type: Drug, Biological, Procedure
Study Drugs: Duvelisib, Nivolumab
Study Phase: Phase 1
Phase I/Ib Study of Parsaclisib (INCB50465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (PaR-CHOP) Immunochemotherapy for Patients With Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma
Phase I/Ib Study of Parsaclisib (INCB50465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (PaR-CHOP) Immunochemotherapy for Patients With Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: September 10, 2025
Intervention Type: Drug, Biological
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Parsaclisib, Pegfilgrastim, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 1
A Phase Ia/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients With CLL/SLL or Non-Hodgkin's Lymphomas
A Phase Ia/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients With CLL/SLL or Non-Hodgkin's Lymphomas
Enrollment Status: Terminated
Publish Date: March 07, 2025
Intervention Type: Drug
Study Drug: CG-806
Study Phase: Phase 1
Phase II Expansion Cohorts Studies of a Novel Triple Combination Therapy, DTRM-555, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Non-Hodgkin's Lymphomas
Phase II Expansion Cohorts Studies of a Novel Triple Combination Therapy, DTRM-555, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Non-Hodgkin's Lymphomas
Enrollment Status: Terminated
Publish Date: January 08, 2025
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 2
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
A Phase 2 Trial of the Combination of Polatuzumab Vedotin, Venetoclax and Rituximab and Hyaluronidase Human for Relapsed and Refractory Mantle Cell Lymphoma
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Biological, Drug
Study Drugs: Polatuzumab Vedotin, Rituximab, Hyaluronidase Human, Venetoclax
Study Phase: Phase 2
A Phase Ia/Ib Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, DTRM-505 and DTRM-555, in Patients With Chronic Lymphocytic Leukemia or Other B-cell Lymphomas
A Phase Ia/Ib Study of a Novel BTK Inhibitor, DTRMWXHS-12, and Combination Products, DTRM-505 and DTRM-555, in Patients With Chronic Lymphocytic Leukemia or Other B-cell Lymphomas
Enrollment Status: Completed
Publish Date: November 27, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

109 Total Publications

Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.
Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.
Journal: Cancers
Published: September 16, 2025
Similar Doctors
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Devinder P. Singh
Hematology Oncology | Hematology | Oncology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Devinder P. Singh
Hematology Oncology | Hematology | Oncology

Honorhealth Ambulatory

5750 W Thunderbird Rd, Suite C300, 
Glendale, AZ 
 (13.2 miles away)
855-485-4673
Languages Spoken:
English, Hindi, Punjabi
See accepted insurances
Accepting New Patients
Offers Telehealth

Devinder Singh is a Hematologist Oncology specialist and a Hematologist in Glendale, Arizona. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Waldenstrom Macroglobulinemia, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Large-Cell Immunoblastic Lymphoma. Dr. Singh is currently accepting new patients.

Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Joan M. Dahmer
Hematology Oncology | Hematology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Joan M. Dahmer
Hematology Oncology | Hematology

Honorhealth Ambulatory

10460 N 92nd St, Suite 200, 
Scottsdale, AZ 
 (6.8 miles away)
855-485-4673
Languages Spoken:
English, French, German, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Joan Dahmer is a Hematologist Oncology specialist and a Hematologist in Scottsdale, Arizona. Dr. Dahmer is rated as a Distinguished provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Dahmer is currently accepting new patients.

Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Rohan Sharma
Hematology Oncology | Hematology | Oncology
Experienced in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections
Dr. Rohan Sharma
Hematology Oncology | Hematology | Oncology

Honorhealth Ambulatory

9003 E Shea Blvd, Suite Hg, 
Scottsdale, AZ 
 (6.7 miles away)
480-323-4973
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rohan Sharma is a Hematologist Oncology specialist and a Hematologist in Scottsdale, Arizona. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections. His top areas of expertise are Acute Mountain Sickness, Idiopathic Pulmonary Hemosiderosis, Hemosiderosis, Pulmonary Embolism, and Carotid Artery Surgery. Dr. Sharma is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenthal's expertise for a condition
ConditionClose
View All 19 Distinguished Conditions
View All 10 Advanced Conditions
View All 92 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile